< Back to latest news & events

HGF Presents

Added Matter – Part 2

September 2025

Video overview:

Pre- and Post-Grant Amendments are governed by Articles 123(2) & 123(3) EPC respectively

  • Before grant, amendments can broaden the claim scope as long as the resulting claim is clearly and unambiguously disclosed in the original application (Article 123(2) EPC).
  • Common pitfalls include intermediate generalisations and shrinking/cherry-picked lists, both of which may introduce a combination of features not clearly and unambiguously disclosed originally. To avoid this, applicants should try to: 
    • provide a general basis for all features in isolation as well as desired combinations of features to provide useful fallback positions;
    • provide a pointer to particular selections from long lists;  and 
    • not rely solely on Figures for support.
  • After grant, broadening the claim scope (e.g. by Deleting limiting features) is not allowed.
  • A Patentee may find themselves in theinescapable trap if a pre-grant amendment adds matter under Article 123(2) EPC, and it cannot be remedied post-grant without broadening the claim which would violate Article 123(3) EPC. 
  • The Result of the Inescapable trap is therefore that the Patent may is held to be invalid, and cannot be rescued via amendment.
  • Careful drafting and amendment strategy is therefore essential to avoid this legal pitfall.

Latest updates

Regulatory Exclusivity for
Medicinal Products in Europe

Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. No exclusivity granted for new formulations or routes of …

Read article

Added Matter - Part 2

Video overview: Pre- and Post-Grant Amendments are governed by Articles 123(2) & 123(3) EPC respectively Before grant, amendments can broaden the claim scope as long as the resulting claim is …

Read article

Added Matter - Part 1

Video overview: What is Added Matter? Added matter occurs when an amendment introduces content that goes beyond what was originally disclosed in the application as filed (Article 123(2) EPC). EPO …

Read article

Patenting Polymorphs at the EPO

Video overview: Novelty and Inventive Step Prior art must necessarily lead to the claimed polymorph to be novelty destroying Watch out for inherent disclosures in prior art—methods may implicitly produce …

Read article

Antibodies

Video overview: EPO Requirements for Antibody Applications The EPO Guidelines (G-II, 6) provide a standardised framework for antibody-related patent issues. Antibodies can be defined by various aspects, including but not …

Read article

Description Amendment Requirements at EPO

Video overview: At the final stage of prosecution, the EPO increasingly insists each patent description must align with the allowed claims to improve clarity and eliminate inconsistencies. However, this strict …

Read article

Computer-implemented Inventions

Video overview: To obtain a patent for a CII in Europe, two main hurdles must be cleared: Eligibility A claim must have technical character—even one technical feature is enough. Examples …

Read article

Bioinformatics at the EPO

Video overview: New Medical Products 8 years of data exclusivity, followed by 2 years of market exclusivity. +1 year market exclusivity possible for a new indication showing significant clinical benefit. …

Read article